Clinical trial
Comparison of Abacavir Following Once-Daily And Twice-Daily Administration In…
NCT00320307 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00320307 |
|---|---|
| Title | Comparison of Abacavir Following Once-Daily And Twice-Daily Administration In HIV Infected Subjects |
| Official title | An Open-Label, Two-Period, Crossover, Pharmacokinetic Study of Abacavir and Its Intracellular Anabolite Carbovir Triphosphate Following Once-Daily and Twice-Daily Administration of Abacavir in HIV-Infected Subjects. |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | HIV Infection |
| Intervention type | Drug |
| Interventions | abacavir |
| Enrollment | 30 |
| Start date | Sep 1, 2005 |
| First posted | May 3, 2006 |
| Last update posted | Oct 16, 2008 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: